首页 > 最新文献

Journal of neuroendovascular therapy最新文献

英文 中文
First Experience with Endovascular Treatment of Cerebral Aneurysms Using Sub-Marker Catheter. 使用 Sub-Marker 导管进行脑动脉瘤血管内治疗的首次经验。
Pub Date : 2024-01-01 Epub Date: 2024-10-04 DOI: 10.5797/jnet.oa.2024-0050
Hideaki Shigematsu, Azusa Sunaga, Takuya Yonemochi, Akihiro Hirayama, Takatoshi Sorimachi, Masamichi Takahashi

Objective: Prehension of the position of the microcatheter tip under fluoroscopy during cerebral aneurysm embolization is critical to prevent intraoperative rupture of the aneurysm, even if the first marker at the tip is obscured by coils in the aneurysm. This study presents our initial experience with a sub-marker catheter, which includes an additional marker positioned 5 mm from the tip, designed to facilitate accurate positioning of the microcatheter tip.

Methods: We analyzed cases of cerebral aneurysms treated with sub-marker catheters at our hospital from July 2022 to September 2023. Single catheter embolization served as the primary treatment option, with balloon-assisted or stent-assisted techniques utilized only when necessary.

Results: During the study period, 18 patients with cerebral aneurysms were treated using sub-marker catheters. The median age of these patients was 65 years, comprising 8 men and 10 women. The aneurysms had a median maximum diameter of 6.2 mm, ranging from 5.0 to 16.8 mm. Among the 18 treated patients, 14 had unruptured aneurysms and 4 had ruptured aneurysms. Treatment methods included single catheter embolization in 10 patients, double catheter embolization in 3, stent-assisted embolization in 3, balloon-assisted embolization in 1, and flow diverter placement combined with coil embolization in 1. The sub-marker was consistently visible under fluoroscopy, aiding the precise positioning of the microcatheter tip without interference from the coils. No complications occurred, and successful embolization was achieved in all cases.

Conclusion: The sub-marker catheter appears valuable for safely performing aneurysm embolization.

目的:在脑动脉瘤栓塞术中,即使顶端的第一个标记被动脉瘤中的线圈遮挡,在透视下预知微导管顶端的位置对于防止术中动脉瘤破裂也至关重要。本研究介绍了我们使用亚标记导管的初步经验,该导管包括一个额外的标记,位于距顶端 5 毫米处,目的是便于准确定位微导管顶端:我们分析了 2022 年 7 月至 2023 年 9 月本院使用亚标记导管治疗脑动脉瘤的病例。单导管栓塞是主要的治疗方案,只有在必要时才使用球囊辅助或支架辅助技术:研究期间,18 名脑动脉瘤患者接受了亚标记导管治疗。这些患者的中位年龄为 65 岁,其中男性 8 人,女性 10 人。动脉瘤的中位最大直径为 6.2 毫米,从 5.0 毫米到 16.8 毫米不等。在接受治疗的 18 名患者中,14 人的动脉瘤未破裂,4 人的动脉瘤破裂。治疗方法包括:10 例患者的单导管栓塞术、3 例患者的双导管栓塞术、3 例患者的支架辅助栓塞术、1 例患者的球囊辅助栓塞术、1 例患者的血流分流器置入术和线圈栓塞术。子标记在透视下始终可见,有助于精确定位微导管尖端,而不受线圈的干扰。无并发症发生,所有病例均成功栓塞:结论:亚标记导管对安全进行动脉瘤栓塞治疗很有价值。
{"title":"First Experience with Endovascular Treatment of Cerebral Aneurysms Using Sub-Marker Catheter.","authors":"Hideaki Shigematsu, Azusa Sunaga, Takuya Yonemochi, Akihiro Hirayama, Takatoshi Sorimachi, Masamichi Takahashi","doi":"10.5797/jnet.oa.2024-0050","DOIUrl":"10.5797/jnet.oa.2024-0050","url":null,"abstract":"<p><strong>Objective: </strong>Prehension of the position of the microcatheter tip under fluoroscopy during cerebral aneurysm embolization is critical to prevent intraoperative rupture of the aneurysm, even if the first marker at the tip is obscured by coils in the aneurysm. This study presents our initial experience with a sub-marker catheter, which includes an additional marker positioned 5 mm from the tip, designed to facilitate accurate positioning of the microcatheter tip.</p><p><strong>Methods: </strong>We analyzed cases of cerebral aneurysms treated with sub-marker catheters at our hospital from July 2022 to September 2023. Single catheter embolization served as the primary treatment option, with balloon-assisted or stent-assisted techniques utilized only when necessary.</p><p><strong>Results: </strong>During the study period, 18 patients with cerebral aneurysms were treated using sub-marker catheters. The median age of these patients was 65 years, comprising 8 men and 10 women. The aneurysms had a median maximum diameter of 6.2 mm, ranging from 5.0 to 16.8 mm. Among the 18 treated patients, 14 had unruptured aneurysms and 4 had ruptured aneurysms. Treatment methods included single catheter embolization in 10 patients, double catheter embolization in 3, stent-assisted embolization in 3, balloon-assisted embolization in 1, and flow diverter placement combined with coil embolization in 1. The sub-marker was consistently visible under fluoroscopy, aiding the precise positioning of the microcatheter tip without interference from the coils. No complications occurred, and successful embolization was achieved in all cases.</p><p><strong>Conclusion: </strong>The sub-marker catheter appears valuable for safely performing aneurysm embolization.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 11","pages":"293-297"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ruptured Occipital Artery Aneurysm Following Craniotomy in a Patient with Neurofibromatosis Type 1: Case Report. 神经纤维瘤病 1 型患者开颅手术后枕动脉动脉瘤破裂:病例报告。
Pub Date : 2024-01-01 Epub Date: 2024-04-16 DOI: 10.5797/jnet.cr.2023-0098
Yuhei Ito, Takao Kojima, Mio Endo, Kiyoshi Saito, Takuya Maeda, Masazumi Fujii

Objective: Neurofibromatosis type 1 (NF1) is associated with vascular fragility, which results in aneurysms, arteriovenous fistulas, and dissections. Here, we describe a case of endovascular treatment of a ruptured occipital artery aneurysm that occurred after a craniotomy in a patient with NF1.

Case presentation: A 46-year-old man with a history of NF1 underwent a right lateral suboccipital craniotomy to remove a cavernous hemangioma in the right middle cerebellar peduncle. Severe bleeding occurred in the occipital artery during the craniotomy. Due to vessel fragility, coagulation and ligation were not possible, and pressure hemostasis was achieved using cellulose oxide and fibrin glue. On postoperative day 12, the patient developed a sudden swelling on the right side of the neck as well as tracheal compression. Contrast-enhanced CT revealed a ruptured aneurysm in the right occipital artery. Transarterial embolization was performed under general anesthesia the same day. Right external carotid angiography showed an 18-mm-diameter fusiform aneurysm in the occipital artery. The aneurysm ruptured inferiorly to form a large pseudoaneurysm with significant jet flow. An arteriovenous fistula was also observed in a nearby vein. A microcatheter was inserted into the fusiform aneurysm under proximal blood flow control, and embolization was performed using coils and N-butyl-2-cyanoacrylate.

Conclusion: Compared to surgical repair of ruptured occipital artery aneurysms, endovascular treatment appears to be safe, effective, minimally invasive, and rapid. Ruptured occipital artery aneurysms in NF1 patients can cause neck swelling and airway compression and should be recognized as a potentially lethal condition.

目的:神经纤维瘤病 1 型(NF1)与血管脆性有关,可导致动脉瘤、动静脉瘘和血管离断。在此,我们描述了一例 NF1 患者在开颅手术后发生枕动脉动脉瘤破裂的血管内治疗病例:一名有NF1病史的46岁男子接受了右外侧枕骨下开颅手术,以切除右侧小脑中梗的海绵状血管瘤。在开颅手术中,枕动脉发生严重出血。由于血管脆弱,无法进行凝固和结扎,只能使用氧化纤维素和纤维蛋白胶进行压迫止血。术后第 12 天,患者颈部右侧突然肿胀,气管受压。对比增强 CT 显示右枕动脉动脉瘤破裂。当天在全身麻醉下进行了经动脉栓塞术。右颈外动脉造影显示枕动脉有一个直径 18 毫米的纺锤形动脉瘤。动脉瘤向下破裂,形成一个巨大的假性动脉瘤,并伴有明显的喷射流。在附近的静脉还发现了动静脉瘘。在近端血流控制下,将微导管插入纺锤形动脉瘤,并使用线圈和 N-丁基-2-氰基丙烯酸酯进行栓塞:结论:与枕动脉动脉瘤破裂的手术修复相比,血管内治疗似乎安全、有效、微创且快速。NF1患者枕动脉瘤破裂可导致颈部肿胀和气道受压,应被视为潜在的致命疾病。
{"title":"Ruptured Occipital Artery Aneurysm Following Craniotomy in a Patient with Neurofibromatosis Type 1: Case Report.","authors":"Yuhei Ito, Takao Kojima, Mio Endo, Kiyoshi Saito, Takuya Maeda, Masazumi Fujii","doi":"10.5797/jnet.cr.2023-0098","DOIUrl":"10.5797/jnet.cr.2023-0098","url":null,"abstract":"<p><strong>Objective: </strong>Neurofibromatosis type 1 (NF1) is associated with vascular fragility, which results in aneurysms, arteriovenous fistulas, and dissections. Here, we describe a case of endovascular treatment of a ruptured occipital artery aneurysm that occurred after a craniotomy in a patient with NF1.</p><p><strong>Case presentation: </strong>A 46-year-old man with a history of NF1 underwent a right lateral suboccipital craniotomy to remove a cavernous hemangioma in the right middle cerebellar peduncle. Severe bleeding occurred in the occipital artery during the craniotomy. Due to vessel fragility, coagulation and ligation were not possible, and pressure hemostasis was achieved using cellulose oxide and fibrin glue. On postoperative day 12, the patient developed a sudden swelling on the right side of the neck as well as tracheal compression. Contrast-enhanced CT revealed a ruptured aneurysm in the right occipital artery. Transarterial embolization was performed under general anesthesia the same day. Right external carotid angiography showed an 18-mm-diameter fusiform aneurysm in the occipital artery. The aneurysm ruptured inferiorly to form a large pseudoaneurysm with significant jet flow. An arteriovenous fistula was also observed in a nearby vein. A microcatheter was inserted into the fusiform aneurysm under proximal blood flow control, and embolization was performed using coils and <i>N</i>-butyl-2-cyanoacrylate.</p><p><strong>Conclusion: </strong>Compared to surgical repair of ruptured occipital artery aneurysms, endovascular treatment appears to be safe, effective, minimally invasive, and rapid. Ruptured occipital artery aneurysms in NF1 patients can cause neck swelling and airway compression and should be recognized as a potentially lethal condition.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 6","pages":"177-181"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189781/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141443860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dural Arteriovenous Fistula Treated with Transvenous Embolization via the Upper Limb Cutaneous Vein. 通过上肢皮肤静脉经静脉栓塞治疗硬脑膜动静脉瘘。
Pub Date : 2024-01-01 Epub Date: 2024-03-19 DOI: 10.5797/jnet.tn.2023-0094
Toshinari Meguro, Yuma Tada, Miki Taniguchi, Shuji Hamauchi, Toru Fukuhara, Yasuyuki Miyoshi, Sigeki Ono

Objective: In recent years, the transradial artery approach has gained prominence and is increasingly employed in neurovascular angiography and therapy due to its safety, reduced complications, and minimal invasiveness. While various venous approaches, including the conventional transfemoral vein approach, exist for procedures such as transvenous embolization, recent reports have highlighted methods involving upper extremity cutaneous veins. However, the practicality and efficacy of these approaches remain unclear.

Case presentations: This study presents our experience with three cases of dural arteriovenous fistulas, where transvenous embolization was performed via upper limb cutaneous veins. In all instances, the arteriovenous approach was successfully executed using a single upper extremity, leading to the successful completion of treatment.

Conclusion: This technique demonstrates significant advantages, not only in terms of its minimal invasiveness but also due to its simplicity and safety. Anticipating broader acceptance in the future, this approach offers a promising avenue for further exploration in neurovascular interventions.

目的:近年来,经桡动脉入路因其安全、减少并发症和微创性而在神经血管造影和治疗中得到越来越多的应用。在经静脉栓塞等手术中,存在各种静脉入路,包括传统的经股静脉入路,而最近的报道则强调了涉及上肢皮肤静脉的方法。然而,这些方法的实用性和有效性仍不明确:本研究介绍了我们在三例硬脑膜动静脉瘘病例中通过上肢皮静脉进行经静脉栓塞的经验。在所有病例中,动静脉栓塞方法都是通过单个上肢成功实施的,从而顺利完成了治疗:结论:这项技术具有显著优势,不仅创口小,而且简单安全。预计这种方法将来会被更多人接受,为进一步探索神经血管介入治疗提供了一个前景广阔的途径。
{"title":"Dural Arteriovenous Fistula Treated with Transvenous Embolization via the Upper Limb Cutaneous Vein.","authors":"Toshinari Meguro, Yuma Tada, Miki Taniguchi, Shuji Hamauchi, Toru Fukuhara, Yasuyuki Miyoshi, Sigeki Ono","doi":"10.5797/jnet.tn.2023-0094","DOIUrl":"10.5797/jnet.tn.2023-0094","url":null,"abstract":"<p><strong>Objective: </strong>In recent years, the transradial artery approach has gained prominence and is increasingly employed in neurovascular angiography and therapy due to its safety, reduced complications, and minimal invasiveness. While various venous approaches, including the conventional transfemoral vein approach, exist for procedures such as transvenous embolization, recent reports have highlighted methods involving upper extremity cutaneous veins. However, the practicality and efficacy of these approaches remain unclear.</p><p><strong>Case presentations: </strong>This study presents our experience with three cases of dural arteriovenous fistulas, where transvenous embolization was performed via upper limb cutaneous veins. In all instances, the arteriovenous approach was successfully executed using a single upper extremity, leading to the successful completion of treatment.</p><p><strong>Conclusion: </strong>This technique demonstrates significant advantages, not only in terms of its minimal invasiveness but also due to its simplicity and safety. Anticipating broader acceptance in the future, this approach offers a promising avenue for further exploration in neurovascular interventions.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 5","pages":"142-148"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129054/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technique for Recanalization of Sheath Introducer Occlusion due to Captured Thrombus during Mechanical Thrombectomy for Acute Ischemic Stroke: A Technical Note. 治疗急性缺血性脑卒中的机械取栓术中因血栓栓塞导致鞘导管闭塞的再通术:技术说明。
Pub Date : 2024-01-01 Epub Date: 2024-03-19 DOI: 10.5797/jnet.tn.2023-0099
Yukitaka Ishida, Toru Umehara, Yoshihiro Yano, Shogo Taniwaki, Hidekazu Nakata, Takashi Koyama, Manabu Sasaki, Koichi Taniwaki, Toshiaki Fujita, Mamoru Taneda, Haruhiko Kishima

Objective: Mechanical thrombectomy (MT) is the gold standard treatment for acute ischemic stroke. During these interventions, a thrombus frequently obstructs a guiding catheter. The obstructed guiding catheter should be withdrawn before distal embolism occurs; however, albeit infrequently, the thrombus occludes even a sheath introducer (SI). While conventionally new SI placement is required for continuation of treatment, we propose a viable alternative for recanalization of the occluded SI, termed vacuum-assisted delivery of thrombus (VADT), with a clinical report of our cases. The usefulness of this technique was also evaluated in simulation experiments.

Case presentations: The VADT procedure is as follows: 1) insert a peel-away sheath, originally attached to a balloon-guiding catheter (BGC), into the SI to continuously open the hemostatic valve; 2) advance the BGC into the peel-away sheath while applying mechanical aspiration; and 3) remove the peel-away sheath/BGC assembly slowly. In a simulation environment using an artificial thrombus, we repeated the VADT procedure five times and reproducibly achieved SI reopening within only 10-20 seconds. From March 2013 to September 2022, 204 patients were treated with MT at our stroke center and SI occlusion occurred in three patients (1.5%). These events occurred exclusively in patients with extracranial internal carotid artery occlusion. All three patients with SI occlusion underwent successfully thrombus extraction in the SI using the VADT on the first try.

Conclusion: The results of clinical experience and simulation experiments strongly support VADT as a reliable option for recanalization of an occluded SI.

目的:机械血栓切除术(MT)是治疗急性缺血性脑卒中的金标准疗法。在这些介入治疗过程中,血栓经常会阻塞导引导管。受阻的导引导管应在远端栓塞发生前拔出;然而,血栓甚至会堵塞鞘状导引管(SI),尽管这种情况并不常见。虽然传统上需要放置新的 SI 以继续治疗,但我们提出了一种可行的替代方法来重新疏通闭塞的 SI,即真空辅助血栓输送(VADT),并对我们的病例进行了临床报告。病例介绍:VADT 过程如下:1)将原本连接在球囊导引导管(BGC)上的剥离鞘插入 SI,持续打开止血阀;2)将 BGC 推进到剥离鞘中,同时进行机械抽吸;3)缓慢移除剥离鞘/BGC 组件。在使用人工血栓的模拟环境中,我们重复了五次 VADT 过程,并在 10-20 秒内重复实现了 SI 再开放。从 2013 年 3 月到 2022 年 9 月,我们的卒中中心共对 204 名患者进行了 MT 治疗,其中有三名患者(1.5%)发生了 SI 闭塞。这些事件仅发生在颅内颈内动脉闭塞的患者身上。这三例 SI 闭塞患者均在首次尝试时使用 VADT 成功取出了 SI 中的血栓:临床经验和模拟实验的结果有力地证明了 VADT 是重新疏通闭塞的 SI 的可靠选择。
{"title":"Technique for Recanalization of Sheath Introducer Occlusion due to Captured Thrombus during Mechanical Thrombectomy for Acute Ischemic Stroke: A Technical Note.","authors":"Yukitaka Ishida, Toru Umehara, Yoshihiro Yano, Shogo Taniwaki, Hidekazu Nakata, Takashi Koyama, Manabu Sasaki, Koichi Taniwaki, Toshiaki Fujita, Mamoru Taneda, Haruhiko Kishima","doi":"10.5797/jnet.tn.2023-0099","DOIUrl":"10.5797/jnet.tn.2023-0099","url":null,"abstract":"<p><strong>Objective: </strong>Mechanical thrombectomy (MT) is the gold standard treatment for acute ischemic stroke. During these interventions, a thrombus frequently obstructs a guiding catheter. The obstructed guiding catheter should be withdrawn before distal embolism occurs; however, albeit infrequently, the thrombus occludes even a sheath introducer (SI). While conventionally new SI placement is required for continuation of treatment, we propose a viable alternative for recanalization of the occluded SI, termed vacuum-assisted delivery of thrombus (VADT), with a clinical report of our cases. The usefulness of this technique was also evaluated in simulation experiments.</p><p><strong>Case presentations: </strong>The VADT procedure is as follows: 1) insert a peel-away sheath, originally attached to a balloon-guiding catheter (BGC), into the SI to continuously open the hemostatic valve; 2) advance the BGC into the peel-away sheath while applying mechanical aspiration; and 3) remove the peel-away sheath/BGC assembly slowly. In a simulation environment using an artificial thrombus, we repeated the VADT procedure five times and reproducibly achieved SI reopening within only 10-20 seconds. From March 2013 to September 2022, 204 patients were treated with MT at our stroke center and SI occlusion occurred in three patients (1.5%). These events occurred exclusively in patients with extracranial internal carotid artery occlusion. All three patients with SI occlusion underwent successfully thrombus extraction in the SI using the VADT on the first try.</p><p><strong>Conclusion: </strong>The results of clinical experience and simulation experiments strongly support VADT as a reliable option for recanalization of an occluded SI.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 5","pages":"149-154"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventive Strategies for Perioperative Ischemic Heart Disease during Carotid Artery Stenting. 颈动脉支架置入术围手术期缺血性心脏病的预防策略。
Pub Date : 2024-01-01 Epub Date: 2024-03-23 DOI: 10.5797/jnet.oa.2023-0062
Shinya Fukuta, Mitsuhiro Iwasaki, Hidekazu Yamazaki, Masahiro Maeda, Masaki Koh, Yasufumi Inaka, Hiroaki Sato, Taichiro Hayase, Masafumi Morimoto

Objectives: We have been performing preoperative coronary artery assessments and implementing coronary revascularization or intraoperative adjunctive therapies as needed in patients scheduled for carotid artery stenting (CAS) to prevent ischemic heart disease. In this study, we report the results of a retrospective observation of patients who underwent CAS under our treatment strategy to prevent perioperative coronary ischemic complications.

Methods: A total of 224 cases from January 2014 to December 2021 were included. Following preoperative coronary artery CTA, preoperative coronary artery treatment or intraoperative adjunctive therapy (temporary transcutaneous cardiac pacemaker [TTCP] or intra-aortic balloon pumping [IABP]) was performed based on the degree of stenosis. We analyzed the outcomes of patients treated with CAS under this strategy at our institution.

Results: Coronary artery disease was detected preoperatively in 143 cases (64%), with 91 cases (41%) indicated for coronary revascularization. Preoperative coronary artery treatment was performed in 76 cases (34%) prior to CAS, and adjunctive therapy with TTCP or IABP was provided in 28 cases (13%) during the procedure. No case developed perioperative coronary ischemic complication.

Conclusion: In patients who have undergone CAS, perioperative coronary ischemic complications might be reduced by evaluating the risk of ischemic heart disease preoperatively, performing pre-CAS coronary artery intervention based on the severity of the lesions, and administering intraoperative adjunctive therapy.

目的:我们一直在对计划接受颈动脉支架植入术(CAS)的患者进行术前冠状动脉评估,并根据需要实施冠状动脉血运重建或术中辅助治疗,以预防缺血性心脏病。在本研究中,我们报告了对在我们的治疗策略下接受 CAS 的患者进行回顾性观察的结果,以预防围手术期冠状动脉缺血性并发症:方法:共纳入 2014 年 1 月至 2021 年 12 月的 224 例患者。术前冠状动脉CTA检查后,根据狭窄程度进行术前冠状动脉治疗或术中辅助治疗(临时经皮心脏起搏器[TTCP]或主动脉内球囊反搏[IABP])。我们分析了本院在此策略下接受 CAS 治疗的患者的疗效:结果:143 例(64%)患者术前发现冠状动脉疾病,其中 91 例(41%)有冠状动脉血运重建指征。76例患者(34%)在CAS术前进行了冠状动脉治疗,28例患者(13%)在术中进行了TTCP或IABP辅助治疗。没有一例患者在围手术期出现冠状动脉缺血并发症:结论:对于接受 CAS 手术的患者,通过术前评估缺血性心脏病的风险、根据病变的严重程度在 CAS 术前进行冠状动脉介入治疗以及术中进行辅助治疗,可以减少围术期冠状动脉缺血并发症的发生。
{"title":"Preventive Strategies for Perioperative Ischemic Heart Disease during Carotid Artery Stenting.","authors":"Shinya Fukuta, Mitsuhiro Iwasaki, Hidekazu Yamazaki, Masahiro Maeda, Masaki Koh, Yasufumi Inaka, Hiroaki Sato, Taichiro Hayase, Masafumi Morimoto","doi":"10.5797/jnet.oa.2023-0062","DOIUrl":"10.5797/jnet.oa.2023-0062","url":null,"abstract":"<p><strong>Objectives: </strong>We have been performing preoperative coronary artery assessments and implementing coronary revascularization or intraoperative adjunctive therapies as needed in patients scheduled for carotid artery stenting (CAS) to prevent ischemic heart disease. In this study, we report the results of a retrospective observation of patients who underwent CAS under our treatment strategy to prevent perioperative coronary ischemic complications.</p><p><strong>Methods: </strong>A total of 224 cases from January 2014 to December 2021 were included. Following preoperative coronary artery CTA, preoperative coronary artery treatment or intraoperative adjunctive therapy (temporary transcutaneous cardiac pacemaker [TTCP] or intra-aortic balloon pumping [IABP]) was performed based on the degree of stenosis. We analyzed the outcomes of patients treated with CAS under this strategy at our institution.</p><p><strong>Results: </strong>Coronary artery disease was detected preoperatively in 143 cases (64%), with 91 cases (41%) indicated for coronary revascularization. Preoperative coronary artery treatment was performed in 76 cases (34%) prior to CAS, and adjunctive therapy with TTCP or IABP was provided in 28 cases (13%) during the procedure. No case developed perioperative coronary ischemic complication.</p><p><strong>Conclusion: </strong>In patients who have undergone CAS, perioperative coronary ischemic complications might be reduced by evaluating the risk of ischemic heart disease preoperatively, performing pre-CAS coronary artery intervention based on the severity of the lesions, and administering intraoperative adjunctive therapy.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 5","pages":"131-136"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11129055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141163211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Lumbar Drainage before Endovascular Treatment for Ruptured Intracranial Aneurysms. 颅内动脉瘤破裂血管内治疗前进行腰椎引流的有效性和安全性
Pub Date : 2024-01-01 Epub Date: 2024-01-13 DOI: 10.5797/jnet.oa.2023-0069
Toshitsugu Terakado, Yoshiro Ito, Koji Hirata, Masayuki Sato, Tomoji Takigawa, Aiki Marushima, Mikito Hayakawa, Wataro Tsuruta, Noriyuki Kato, Yasunobu Nakai, Kensuke Suzuki, Yuji Matsumaru, Eiichi Ishikawa

Objective: Intraoperative rebleeding during endovascular treatment for ruptured intracranial aneurysms is associated with poor prognosis. Lumbar drainage is performed preoperatively to control intracranial pressure; however, it is associated with a risk of brain herniation or rebleeding because intracranial pressure may change rapidly. Therefore, this study aimed to examine the efficacy and safety of preoperative lumbar drainage.

Methods: This retrospective study enrolled 375 patients who underwent endovascular treatment of ruptured intracranial aneurysms at our institution between April 2013 and March 2018. The incidence of rebleeding and clinical outcomes were compared between patients who did and did not undergo preoperative lumbar drainage.

Results: Among the 375 patients with ruptured intracranial aneurysms, 324 (86.0%) and 51 (14.0%) patients did and did not undergo lumbar drainage, respectively. The incidence of rebleeding was 11/324 (3.4%) and 2/51 (3.9%) in lumbar drainage and nonlumbar drainage groups, respectively, with no statistical differences (p = 0.98). Of the rebleeding cases, 9/11 (81%) and 2/2 (100%) in lumbar drainage and nonlumbar drainage groups, respectively, were due to intraoperative bleeding, and 2/11 (19%) in the lumbar drainage group, the causes of the rebleeding were undetermined. The incidence of symptomatic vasospasm did not differ significantly between the groups (13.2% vs. 11.8%, P = 0.776), while the incidence of hydrocephalus (24.6% vs. 11.8%, P = 0.043) and meningitis (15.2% vs. 5.9%, P = 0.075) were slightly higher in the lumbar drainage group. Favorable clinical outcomes (modified Rankin Scale score <2) at discharge were less frequent in the lumbar drainage group (55.3% vs. 70.0%, P = 0.051). No significant differences were observed in the propensity score-matched analysis.

Conclusion: Lumbar drainage before endovascular treatment for ruptured intracranial aneurysms is a safe procedure that does not increase the incidence of rebleeding.

目的:血管内治疗颅内动脉瘤破裂期间的术中再出血与预后不良有关。术前进行腰椎引流术可控制颅内压,但由于颅内压可能迅速变化,因此存在脑疝或再出血的风险。因此,本研究旨在探讨术前腰椎引流的有效性和安全性:这项回顾性研究纳入了 2013 年 4 月至 2018 年 3 月期间在我院接受血管内治疗的 375 例颅内动脉瘤破裂患者。比较了术前接受和未接受腰椎引流术的患者再出血的发生率和临床预后:在375例颅内动脉瘤破裂患者中,分别有324例(86.0%)和51例(14.0%)患者接受和未接受腰椎引流术。腰部引流组和非腰部引流组的再出血发生率分别为 11/324(3.4%)和 2/51(3.9%),无统计学差异(P = 0.98)。在再出血病例中,腰椎引流组和非腰椎引流组分别有 9/11 例(81%)和 2/2 例(100%)是由于术中出血,腰椎引流组有 2/11 例(19%)再出血原因不明。两组症状性血管痉挛的发生率无明显差异(13.2% 对 11.8%,P = 0.776),而腰椎引流组脑积水(24.6% 对 11.8%,P = 0.043)和脑膜炎(15.2% 对 5.9%,P = 0.075)的发生率略高。良好的临床结果(改良Rankin量表评分 结论:腰椎引流术后的临床结果良好:在血管内治疗颅内动脉瘤破裂前进行腰椎引流术是一种安全的手术,不会增加再出血的发生率。
{"title":"Efficacy and Safety of Lumbar Drainage before Endovascular Treatment for Ruptured Intracranial Aneurysms.","authors":"Toshitsugu Terakado, Yoshiro Ito, Koji Hirata, Masayuki Sato, Tomoji Takigawa, Aiki Marushima, Mikito Hayakawa, Wataro Tsuruta, Noriyuki Kato, Yasunobu Nakai, Kensuke Suzuki, Yuji Matsumaru, Eiichi Ishikawa","doi":"10.5797/jnet.oa.2023-0069","DOIUrl":"10.5797/jnet.oa.2023-0069","url":null,"abstract":"<p><strong>Objective: </strong>Intraoperative rebleeding during endovascular treatment for ruptured intracranial aneurysms is associated with poor prognosis. Lumbar drainage is performed preoperatively to control intracranial pressure; however, it is associated with a risk of brain herniation or rebleeding because intracranial pressure may change rapidly. Therefore, this study aimed to examine the efficacy and safety of preoperative lumbar drainage.</p><p><strong>Methods: </strong>This retrospective study enrolled 375 patients who underwent endovascular treatment of ruptured intracranial aneurysms at our institution between April 2013 and March 2018. The incidence of rebleeding and clinical outcomes were compared between patients who did and did not undergo preoperative lumbar drainage.</p><p><strong>Results: </strong>Among the 375 patients with ruptured intracranial aneurysms, 324 (86.0%) and 51 (14.0%) patients did and did not undergo lumbar drainage, respectively. The incidence of rebleeding was 11/324 (3.4%) and 2/51 (3.9%) in lumbar drainage and nonlumbar drainage groups, respectively, with no statistical differences (p = 0.98). Of the rebleeding cases, 9/11 (81%) and 2/2 (100%) in lumbar drainage and nonlumbar drainage groups, respectively, were due to intraoperative bleeding, and 2/11 (19%) in the lumbar drainage group, the causes of the rebleeding were undetermined. The incidence of symptomatic vasospasm did not differ significantly between the groups (13.2% vs. 11.8%, P = 0.776), while the incidence of hydrocephalus (24.6% vs. 11.8%, P = 0.043) and meningitis (15.2% vs. 5.9%, P = 0.075) were slightly higher in the lumbar drainage group. Favorable clinical outcomes (modified Rankin Scale score <2) at discharge were less frequent in the lumbar drainage group (55.3% vs. 70.0%, P = 0.051). No significant differences were observed in the propensity score-matched analysis.</p><p><strong>Conclusion: </strong>Lumbar drainage before endovascular treatment for ruptured intracranial aneurysms is a safe procedure that does not increase the incidence of rebleeding.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 2","pages":"29-36"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10878735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139934485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular Treatment of Bifurcation Aneurysms with the Woven EndoBridge: Product Features and Selected Results of Off-Label Use. 使用编织 EndoBridge 对分叉动脉瘤进行血管内治疗:产品特点和标示外使用的部分结果。
Pub Date : 2024-01-01 Epub Date: 2024-02-22 DOI: 10.5797/jnet.ra.2023-0086
Kohsuke Teranishi, Ryogo Ikemura, Sho Arai, Yumiko Mitome-Mishima, Takayuki Kitamura, Akihide Kondo, Hidenori Oishi

Treatment for wide-neck bifurcation cerebral aneurysms (WNBAs) is widely performed by endovascular treatment as well as open surgical clipping. However, due to factors such as the shape and size of the aneurysms, as well as the anatomical features of surrounding branch vessels, there are some cases in which simple coiling or conventional adjunctive techniques, such as balloon-assisted or neck bridge stent-assisted coiling, are not sufficient to achieve a satisfactory cure. Against this backdrop, the device known as the Woven EndoBridge (WEB) (MicroVention, Aliso Viejo, CA, USA) was developed and can be deployed directly into the aneurysm for treatment. Over a decade has passed since its development, and it is now used in many countries worldwide. This review provides insights into the evolution of the WEB device from its development to the date of this writing, highlighting the unique features of the device and its treatment indications. Additionally, it discusses the posttreatment course, perspectives on recurrence and retreatment, imaging assessments, and potential off-label use based on numerous studies primarily conducted in Europe and the USA.

宽颈分叉脑动脉瘤(WNBAs)的治疗广泛采用血管内治疗和开放性手术切除。然而,由于动脉瘤的形状和大小以及周围分支血管的解剖特征等因素,在某些情况下,简单的卷曲或传统的辅助技术(如球囊辅助或颈桥支架辅助卷曲)不足以达到满意的治愈效果。在此背景下,一种名为 Woven EndoBridge(WEB)(MicroVention,美国加利福尼亚州阿利索维埃霍市)的设备应运而生,该设备可直接放入动脉瘤内进行治疗。自开发以来已过去十多年,目前已在全球许多国家使用。本综述深入探讨了 WEB 设备从开发到本文撰写之日的演变过程,重点介绍了该设备的独特功能及其治疗适应症。此外,它还根据主要在欧洲和美国进行的大量研究,讨论了治疗后的过程、对复发和再治疗的看法、成像评估以及可能的标签外使用。
{"title":"Endovascular Treatment of Bifurcation Aneurysms with the Woven EndoBridge: Product Features and Selected Results of Off-Label Use.","authors":"Kohsuke Teranishi, Ryogo Ikemura, Sho Arai, Yumiko Mitome-Mishima, Takayuki Kitamura, Akihide Kondo, Hidenori Oishi","doi":"10.5797/jnet.ra.2023-0086","DOIUrl":"10.5797/jnet.ra.2023-0086","url":null,"abstract":"<p><p>Treatment for wide-neck bifurcation cerebral aneurysms (WNBAs) is widely performed by endovascular treatment as well as open surgical clipping. However, due to factors such as the shape and size of the aneurysms, as well as the anatomical features of surrounding branch vessels, there are some cases in which simple coiling or conventional adjunctive techniques, such as balloon-assisted or neck bridge stent-assisted coiling, are not sufficient to achieve a satisfactory cure. Against this backdrop, the device known as the Woven EndoBridge (WEB) (MicroVention, Aliso Viejo, CA, USA) was developed and can be deployed directly into the aneurysm for treatment. Over a decade has passed since its development, and it is now used in many countries worldwide. This review provides insights into the evolution of the WEB device from its development to the date of this writing, highlighting the unique features of the device and its treatment indications. Additionally, it discusses the posttreatment course, perspectives on recurrence and retreatment, imaging assessments, and potential off-label use based on numerous studies primarily conducted in Europe and the USA.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 3","pages":"65-74"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10973567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140337922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences and Advantages of Particles versus Liquid Material for Preoperative Intracranial Tumor Embolization: A Retrospective Multicenter Study. 用于术前颅内肿瘤栓塞的颗粒与液体材料的差异和优势:一项回顾性多中心研究。
Pub Date : 2024-01-01 Epub Date: 2024-02-20 DOI: 10.5797/jnet.oa.2023-0083
Yu Iida, Taisuke Akimoto, Shigeta Miyake, Ryosuke Suzuki, Wataru Shimohigoshi, Satoshi Hori, Jun Suenaga, Yasunobu Nakai, Katsumi Sakata, Tetsuya Yamamoto

Objectives: The superiority and usefulness of liquid material over particles for embolization have been a topic of debate due to differences in materials and techniques. This study aimed to identify the complications and outcomes associated with both embolization materials.

Methods: This retrospective multicenter cohort study included 93 patients from an endovascular treatment registry, treated from January 1, 2018 to May 31, 2022. It included patients who underwent preoperative embolization for meningioma, solitary fibrous tumor/hemangiopericytoma, and hemangioblastoma. Data for patient characteristics, procedural factors, complications, and outcomes were collected from medical records.

Results: A tortuous access route was the only factor independently associated with complications (p = 0.020). Although liquid material was more frequently used for embolization in relatively high-risk conditions, complication rates did not differ significantly between the groups (p = 0.999). In the liquid material group, the tip of the microcatheter could be guided closer to the tumor (p <0.001) using a distal access catheter and flow-guide microcatheters. The subgroup middle meningeal artery embolization had less operative bleeding in the liquid material group (p <0.001), whereas the particles group exhibited less intraoperative blood loss than the liquid material group (p = 0.006).

Conclusion: The vascular tortuosity of the access route was only associated with complications in preoperative tumor embolization. Liquid material and particles showed no difference in complication rates. The use of particles in embolization may reduce intraoperative bleeding, but not in all cases can it be used safely. Therefore, a thorough understanding of the characteristics of both approaches and their relative advantages in clinical practice is essential to opt for the appropriate material according to the case.

目的:由于栓塞材料和技术的不同,液体栓塞材料比颗粒栓塞材料更优越、更有用一直是一个争论的话题。本研究旨在确定两种栓塞材料的相关并发症和结果:这项回顾性多中心队列研究纳入了血管内治疗登记处的 93 名患者,治疗时间为 2018 年 1 月 1 日至 2022 年 5 月 31 日。其中包括因脑膜瘤、单发纤维瘤/血管瘤和血管母细胞瘤接受术前栓塞治疗的患者。从病历中收集了患者特征、手术因素、并发症和结果等数据:迂曲的入路是唯一与并发症独立相关的因素(p = 0.020)。虽然在相对高风险的情况下,液体材料更常用于栓塞,但两组的并发症发生率并无显著差异(p = 0.999)。在液体材料组中,微导管的顶端可以更靠近肿瘤(p p = 0.006):结论:在术前肿瘤栓塞中,入路血管迂曲只与并发症有关。液体材料和微粒在并发症发生率上没有差异。在栓塞术中使用微粒可减少术中出血,但并非在所有情况下都能安全使用。因此,透彻了解这两种方法的特点及其在临床实践中的相对优势对于根据病例选择合适的材料至关重要。
{"title":"Differences and Advantages of Particles versus Liquid Material for Preoperative Intracranial Tumor Embolization: A Retrospective Multicenter Study.","authors":"Yu Iida, Taisuke Akimoto, Shigeta Miyake, Ryosuke Suzuki, Wataru Shimohigoshi, Satoshi Hori, Jun Suenaga, Yasunobu Nakai, Katsumi Sakata, Tetsuya Yamamoto","doi":"10.5797/jnet.oa.2023-0083","DOIUrl":"10.5797/jnet.oa.2023-0083","url":null,"abstract":"<p><strong>Objectives: </strong>The superiority and usefulness of liquid material over particles for embolization have been a topic of debate due to differences in materials and techniques. This study aimed to identify the complications and outcomes associated with both embolization materials.</p><p><strong>Methods: </strong>This retrospective multicenter cohort study included 93 patients from an endovascular treatment registry, treated from January 1, 2018 to May 31, 2022. It included patients who underwent preoperative embolization for meningioma, solitary fibrous tumor/hemangiopericytoma, and hemangioblastoma. Data for patient characteristics, procedural factors, complications, and outcomes were collected from medical records.</p><p><strong>Results: </strong>A tortuous access route was the only factor independently associated with complications (<i>p</i> = 0.020). Although liquid material was more frequently used for embolization in relatively high-risk conditions, complication rates did not differ significantly between the groups (<i>p</i> = 0.999). In the liquid material group, the tip of the microcatheter could be guided closer to the tumor (<i>p</i> <0.001) using a distal access catheter and flow-guide microcatheters. The subgroup middle meningeal artery embolization had less operative bleeding in the liquid material group (<i>p</i> <0.001), whereas the particles group exhibited less intraoperative blood loss than the liquid material group (<i>p</i> = 0.006).</p><p><strong>Conclusion: </strong>The vascular tortuosity of the access route was only associated with complications in preoperative tumor embolization. Liquid material and particles showed no difference in complication rates. The use of particles in embolization may reduce intraoperative bleeding, but not in all cases can it be used safely. Therefore, a thorough understanding of the characteristics of both approaches and their relative advantages in clinical practice is essential to opt for the appropriate material according to the case.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 4","pages":"110-118"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11076144/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140892969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Considerations and Literature Review for Treating Subarachnoid Hemorrhage due to Blood Blister-Like Aneurysms. 治疗血泡样动脉瘤引起的蛛网膜下腔出血的注意事项和文献综述。
Pub Date : 2024-01-01 Epub Date: 2024-06-11 DOI: 10.5797/jnet.oa.2024-0009
Ryousuke Orimoto, Kouichi Ebiharara, Michihiro Hayasaka

Objective: Subarachnoid hemorrhage (SAH) due to blood blister-like aneurysm (BBA) is rare but very risky during treatment. Moreover, there is no established treatment method. In this study, we performed endovascular treatment (EVT) as the first-line treatment on patients with SAH during the subacute phase, and cases were analyzed in this series.

Methods: Patients with SAH due to BBA who visited our hospital between April 2021 and March 2023 were enrolled in this study. We waited as long as possible during the acute phase and performed EVT during the subacute phase. We performed stent-assisted coiling (SAC) as the first-line treatment and performed DSA approximately 6 months after treatment.

Results: Ninety-six patients with SAH visited our hospital during the study period and six had SAH due to BBAs. There were two males and four females aged 56.2 ± 14.6 years. We performed SAC in five patients, and one died owing to rebleeding before treatment. Two patients received treatments because of rebleeding. One patient died on the day after rebleeding, whereas the other experienced rebleeding and treatments twice and achieved a good outcome. Four patients had good outcomes (modified Rankin scale [mRS]: 0). The surviving patients achieved complete occlusion at follow-up DSA. However, two patients had poor outcomes (mRS: 6).

Conclusion: Patients with SAH due to BBA treated in the subacute phase may achieve good outcomes; however, there is a risk of rebleeding during the waiting period, which often causes poor outcomes.

目的:血泡样动脉瘤(BBA)导致的蛛网膜下腔出血(SAH)非常罕见,但在治疗过程中风险很大。此外,目前还没有成熟的治疗方法。本研究将血管内治疗(EVT)作为亚急性期 SAH 患者的一线治疗方法,并对本系列病例进行了分析:方法:将 2021 年 4 月至 2023 年 3 月期间在我院就诊的 BBA 引起的 SAH 患者纳入本研究。我们在急性期尽量等待,在亚急性期进行 EVT。我们将支架辅助旋切术(SAC)作为一线治疗,并在治疗后约6个月进行DSA:研究期间有96名SAH患者到我院就诊,其中6名患者因BBA引起SAH。其中男性 2 例,女性 4 例,年龄(56.2±14.6)岁。我们为五名患者实施了 SAC,其中一人在治疗前因再出血而死亡。两名患者因再出血接受了治疗。一名患者在再出血的第二天死亡,另一名患者经历了两次再出血和两次治疗,并取得了良好的疗效。四名患者疗效良好(改良兰金量表[mRS]:0)。存活的患者在随访 DSA 时实现了完全闭塞。但有两名患者的预后较差(mRS:6):结论:BBA导致的SAH患者在亚急性阶段接受治疗可能会获得良好的预后;但在等待期间存在再出血的风险,这往往会导致预后不佳。
{"title":"Considerations and Literature Review for Treating Subarachnoid Hemorrhage due to Blood Blister-Like Aneurysms.","authors":"Ryousuke Orimoto, Kouichi Ebiharara, Michihiro Hayasaka","doi":"10.5797/jnet.oa.2024-0009","DOIUrl":"10.5797/jnet.oa.2024-0009","url":null,"abstract":"<p><strong>Objective: </strong>Subarachnoid hemorrhage (SAH) due to blood blister-like aneurysm (BBA) is rare but very risky during treatment. Moreover, there is no established treatment method. In this study, we performed endovascular treatment (EVT) as the first-line treatment on patients with SAH during the subacute phase, and cases were analyzed in this series.</p><p><strong>Methods: </strong>Patients with SAH due to BBA who visited our hospital between April 2021 and March 2023 were enrolled in this study. We waited as long as possible during the acute phase and performed EVT during the subacute phase. We performed stent-assisted coiling (SAC) as the first-line treatment and performed DSA approximately 6 months after treatment.</p><p><strong>Results: </strong>Ninety-six patients with SAH visited our hospital during the study period and six had SAH due to BBAs. There were two males and four females aged 56.2 ± 14.6 years. We performed SAC in five patients, and one died owing to rebleeding before treatment. Two patients received treatments because of rebleeding. One patient died on the day after rebleeding, whereas the other experienced rebleeding and treatments twice and achieved a good outcome. Four patients had good outcomes (modified Rankin scale [mRS]: 0). The surviving patients achieved complete occlusion at follow-up DSA. However, two patients had poor outcomes (mRS: 6).</p><p><strong>Conclusion: </strong>Patients with SAH due to BBA treated in the subacute phase may achieve good outcomes; however, there is a risk of rebleeding during the waiting period, which often causes poor outcomes.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 7","pages":"183-190"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11260517/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asymptomatic Complete Spiral Stent Fracture in Subclavian Artery with Progressive Restenosis in the Early Postoperative Period: A Case Report. 锁骨下动脉无症状完全螺旋支架断裂伴术后早期进行性再狭窄:病例报告。
Pub Date : 2024-01-01 Epub Date: 2024-05-15 DOI: 10.5797/jnet.cr.2024-0019
Daisuke Izawa, Hiroyuki Matsumoto, Yuta Nakanishi, Toshiki Shimizu, Hirokazu Nishiyama

Objective: Stent fractures may be a risk factor for delayed restenosis, but it is difficult to diagnose asymptomatic stent fractures in the subclavian artery (SCA). We report a rare case of percutaneous transluminal angioplasty and stenting (PTAS) for SCA stenosis with asymptomatic severe stent fracture that showed progressive in-stent stenosis in the early postoperative period.

Case presentation: A 70-year-old woman presented with left arm claudication. Magnetic resonance imaging at the time of admission showed SCA stenosis with severe calcification. Because of the left subclavian steal phenomenon on ultrasonography of the left vertebral artery, she underwent PTAS using a balloon-expandable stainless stent. Ultrasonography the day after treatment showed appropriate stent placement. Computed tomography angiography (CTA) 30 days after PTAS showed an asymptomatic complete spiral stent fracture at the mid-portion of the stent. The in-stent stenosis then gradually progressed on follow-up ultrasonography at the site of the stent fracture. Nine months after the first PTAS, a second PTAS using a self-expandable nitinol stent was performed because the peak systolic velocity exceeded 300 cm/s on Doppler ultrasound. Two years after the second PTAS, no neurological symptoms and no stent deformation were observed.

Conclusion: PTAS with a balloon-expandable stainless stent for SCA stenosis with severe calcification may lead to stent fracture. In the case of severe stent fracture, careful follow-up may be needed for the detection of asymptomatic in-stent stenosis in the early postoperative period.

目的:支架断裂可能是延迟再狭窄的一个危险因素,但是很难诊断锁骨下动脉(SCA)无症状支架断裂。我们报告了一例罕见的经皮腔内血管成形术和支架植入术(PTAS)治疗锁骨下动脉狭窄并伴有无症状严重支架骨折的病例,术后早期支架内狭窄呈进行性发展:一名 70 岁的女性因左臂跛行就诊。入院时磁共振成像显示 SCA 狭窄并伴有严重钙化。由于左侧椎动脉超声波检查显示左锁骨下盗血现象,她接受了使用球囊扩张不锈钢支架的 PTAS 治疗。治疗后第二天的超声波检查显示支架放置适当。PTAS 30 天后的计算机断层扫描(CTA)显示,支架中段出现无症状的螺旋支架完全断裂。随访超声波检查显示,支架断裂处的支架内狭窄逐渐加重。第一次 PTAS 九个月后,由于多普勒超声显示收缩峰值速度超过 300 厘米/秒,患者接受了使用自膨胀镍钛诺支架的第二次 PTAS。第二次 PTAS 两年后,患者没有出现神经症状,支架也没有变形:结论:使用可球囊扩张的不锈钢支架治疗伴有严重钙化的 SCA 狭窄,PTAS 可能会导致支架断裂。在支架严重断裂的情况下,可能需要仔细随访,以便在术后早期发现无症状的支架内狭窄。
{"title":"Asymptomatic Complete Spiral Stent Fracture in Subclavian Artery with Progressive Restenosis in the Early Postoperative Period: A Case Report.","authors":"Daisuke Izawa, Hiroyuki Matsumoto, Yuta Nakanishi, Toshiki Shimizu, Hirokazu Nishiyama","doi":"10.5797/jnet.cr.2024-0019","DOIUrl":"10.5797/jnet.cr.2024-0019","url":null,"abstract":"<p><strong>Objective: </strong>Stent fractures may be a risk factor for delayed restenosis, but it is difficult to diagnose asymptomatic stent fractures in the subclavian artery (SCA). We report a rare case of percutaneous transluminal angioplasty and stenting (PTAS) for SCA stenosis with asymptomatic severe stent fracture that showed progressive in-stent stenosis in the early postoperative period.</p><p><strong>Case presentation: </strong>A 70-year-old woman presented with left arm claudication. Magnetic resonance imaging at the time of admission showed SCA stenosis with severe calcification. Because of the left subclavian steal phenomenon on ultrasonography of the left vertebral artery, she underwent PTAS using a balloon-expandable stainless stent. Ultrasonography the day after treatment showed appropriate stent placement. Computed tomography angiography (CTA) 30 days after PTAS showed an asymptomatic complete spiral stent fracture at the mid-portion of the stent. The in-stent stenosis then gradually progressed on follow-up ultrasonography at the site of the stent fracture. Nine months after the first PTAS, a second PTAS using a self-expandable nitinol stent was performed because the peak systolic velocity exceeded 300 cm/s on Doppler ultrasound. Two years after the second PTAS, no neurological symptoms and no stent deformation were observed.</p><p><strong>Conclusion: </strong>PTAS with a balloon-expandable stainless stent for SCA stenosis with severe calcification may lead to stent fracture. In the case of severe stent fracture, careful follow-up may be needed for the detection of asymptomatic in-stent stenosis in the early postoperative period.</p>","PeriodicalId":73856,"journal":{"name":"Journal of neuroendovascular therapy","volume":"18 7","pages":"191-196"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11260515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141750199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of neuroendovascular therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1